Price
No data yet.
Social Signal Score
Revenue
$2.97M+5126.58%Company Profile
- CEO
- Adam L. Hershey
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 91
- Beta
- -0.47
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -6.66
Financials
Revenue
$2.97M+5126.6%Net Income
$-447.6KEBITDA
$377.1KFree Cash Flow
$-177.2KEPS (diluted)
$-0.00Shares Outstanding (diluted)
108.75M+730.4%Operating Expenses
$1.34MCash & Debt
$214.3KReturn of Capital
$0.00Revenue by Segment (annual)
$17.72MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $11.67M | $-842.8K | $-0.01 |
| 2024 | $13.66M | $-3.48M | $-0.03 |
| 2023 | $18.14M | $-7.08M | $-0.06 |
| 2022 | $13.44M | $-9.48M | $-0.10 |
| 2021 | $5.93M | $-8.87M | $-0.13 |
| 2020 | $7.12M | $-7.68M | $-0.17 |
| 2019 | $3.67M | $-14.83M | $-0.39 |
| 2018 | $4.62M | $-16.97M | $-0.49 |
| 2017 | $3.52M | $-8.22M | $-0.40 |
| 2016 | $2.98M | $-32.80M | $-2.12 |
| 2015 | $1.76M | $-8.79M | $-0.63 |
| 2014 | $240.2K | $-6.93M | $-0.51 |
| 2013 | $0.00 | $-1.22M | $-0.09 |
| 2012 | $21.0K | $-20.3K | $-0.00 |
Valuation
CANNhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
130Social Signal Score
Mentions (1)
- Newsbusinesswire.com·6d ago·Positive
The More Life Company Advances Agrarius Commercial Adoption for 384,000 Citrus Trees in Brazil TORONTO--(BUSINESS WIRE)--The More Life Company Corp. (the “Company” or “MLCO”), (CSE: MLCO) (OTC: TMLCF) is pleased to announce that a Brazilian citrus grower whose orchards hosted the Agrarius™ trials has placed an initial order for a planned commercial application program covering approximately 384,000 citrus trees. The order follows positive results from FARMATAC's second-cycle pre-harvest assessme
View source ↗
Insider trading
Open-market buys and sells by CANN officers and directors.
- Bought
- $842k
- Sold
- —
16 trades
0 trades
- Tcm Tactical Opportunities Fund Ii Lpbought
- Tcm Tactical Opportunities Fund Ii Lpbought
- Tcm Tactical Opportunities Fund Ii Lpbought
- Tcm Tactical Opportunities Fund Ii Lpbought
- Gutterman Steven D.bought
- Gutterman Steven D.bought
- Gutterman Steven D.bought
- Gutterman Steven D.bought
84 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in CANN.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
